Globosoft GmbH
Nuremberg
About Globosoft GmbH
Globosoft GmbH aims to optimize the drug development process of drug manufacturers, enabling faster and more efficient development of drugs in Europe and worldwide. For this purpose, Globosoft GmbH has developed the innovative optimization algorithm called BioAhead to optimize acid chain analysis, as part of the protein structure modeling field. The innovation will create growth in terms of income and new job creation and have a high return on investment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $59.5K
- Last round: Grant (Dec 2017)
- Website: globosoft.de
Industries & Categories
Construction, Manufacturing
Canonical: https://fsome.com/organization/globosoft-gmbh-191614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.